Ewing sarcoma cDCs showed significantly lower percentages of CD83-, CD86-, and TNFSF9-expressing cells and Ewing sarcoma Mφ had significantly lower CD70-, CD80-, CD83-, and TNFSF9-expressing cells, than neuroblastoma. This evidence concerns the gene CD86 and neuroblastoma.